跳到正文
原文
Endpoints News 生物医药· Max Bayer·· 2026-10-21AI 评分33

ICER 新报告提示:药品上市价格正超出其价值

New ICER report suggests drug launch prices are outpacing their worth

AI 导读

ICER 新报告提示,药品上市价格正超出其价值。报告称,2022 至 2025 年药品上市时中位标价上涨 24%,净价涨幅更高。

正文

The me­di­an list price of drugs at launch rose 24% from 2022 to 2025, and the net prices of those drugs rose even high­er, ac­cord­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news